Info: Zenodo’s user support line is staffed on regular business days between Dec 23 and Jan 5. Response times may be slightly longer than normal.

Published November 7, 2023 | Version v1
Video/Audio Open

Development of an implantable device for continuous monitoring of blood biomarkers – Dr Chenyang He (University of Nottingham)

  • 1. University of Nottingham

Description

This video is the sixth talk from our Future of Healthcare: Remote Blood Testing, Monitoring & AI Meeting that took place on 07-08/11/2023. 

Development of an implantable device for continuous monitoring of blood biomarkers – Dr Chenyang He (University of Nottingham). 

Bio: Chenyang He is an early career academic at the University of Nottingham and has been engaged in developing various fibre optic bio-/chemical/physiological sensors for healthcare applications. Examples include point-of-care sensors measuring blood and breath biomarkers of disease through medical devices such as optical fibre-based antibody (IgG) monitoring and anti-cancer drug (Dabrafenib) monitoring and a smart wound dressing for monitoring healing and infection of diabetic foot ulcers (biomarkers: temperature, humidity, NH3 and CO2). These utilise a range of different sensing mechanisms including optical gratings, absorption dyes, Fabry-Perot interferometers and plasmonic nanostructures. 

Further details on this event can be found at: https://futurebloodtesting.org/event/the-future-of-healthcare-remote-blood-testing-monitoring-ai/

This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1

YouTube Link: https://www.youtube.com/watch?v=xpB2sznJzqw&list=PL_5Zbof1GNkCZLgQwZnxsMTQUELUCQHlp&index=5

Files

fbtn_7&8_nov_2023_05_dr_chenyang_he_v1 (2160p).mp4

Files (372.7 MB)

Additional details

Funding

Future blood testing for inclusive monitoring and personalised analytics Network+ EP/W000652/1
UK Research and Innovation